Cells with DNA repair defects have increased genomic instability and are more likely to acquire secondary mutations that bring about cellular transformation. We describe the frequency and spectrum of somatic mutations involving several tumor suppressor genes in the rectal carcinoma of a 13-year-old girl harboring biallelic, germline mutations in the DNA mismatch repair gene PMS2. Apart from microsatellite instability, the tumor DNA contained a number of C:G→T:A or G:C→A:T transitions in CpG dinucleotides, which often result through spontaneous deamination of cytosine or 5-methylcytosine. Four DNA glycosylases, UNG2, SMUG1, MBD4 and TDG, are involved in the repair of these deamination events. We identified a heterozygous missense mutation in TDG, which was associated with TDG protein loss in the tumor. The CpGs mutated in this patient's tumor are generally methylated in normal colonic mucosa. Thus, it is highly likely that loss of TDG contributed to the supermutator phenotype and that most of the point mutations were caused by deamination of 5-methylcytosine to thymine, which remained uncorrected owing to the TDG deficiency. This case provides the first in vivo evidence of the key role of TDG in protecting the human genome against the deleterious effects of 5-methylcytosine deamination.

Department of Biology and Medical Genetics Charles University 2nd Faculty of Medicine and University Hospital Motol 5 Uvalu 84 15006 Prague 5 Czech Republic

Zobrazit více v PubMed

Aaltonen L.A., Peltomaki P., Leach F.S., Sistonen P., Pylkkanen L., Mecklin J.P., Jarvinen H., Powell S.M., Jen J., Hamilton S.R. Clues to the pathogenesis of familial colorectal cancer. Science. 1993;260:812–816. PubMed

Lynch H.T., de la Chapelle A. Hereditary colorectal cancer. N. Engl. J. Med. 2003;348:919–932. PubMed

Wimmer K., Etzler J. Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg? Hum. Genet. 2008;124:105–122. PubMed

Huang J., Papadopoulos N., McKinley A.J., Farrington S.M., Curtis L.J., Wyllie A.H., Zheng S., Willson J.K., Markowitz S.D., Morin P., Kinzler K.W., Vogelstein B., Dunlop M.G. APC mutations in colorectal tumors with mismatch repair deficiency. Proc. Natl. Acad. Sci. U.S.A. 1996;93:9049–9054. PubMed PMC

Kinzler K.W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87:159–170. PubMed

Al-Tassan N., Chmiel N.H., Maynard J., Fleming N., Livingston A.L., Williams G.T., Hodges A.K., Davies D.R., David S.S., Sampson J.R., Cheadle J.P. Inherited variants of MYH associated with somatic G:C → T:A mutations in colorectal tumors. Nat. Genet. 2002;30:227–232. PubMed

Cheadle J.P., Sampson J.R. MUTYH-associated polyposis—from defect in base excision repair to clinical genetic testing. DNA Repair. 2007;6:274–279. PubMed

Gallinari P., Jiricny J. A new class of uracil-DNA glycosylases related to human thymine-DNA glycosylase. Nature. 1996;383:735–738. PubMed

Fischer F., Baerenfaller K., Jiricny J. 5-Fluorouracil is efficiently removed from DNA by the base excision and mismatch repair systems. Gastroenterology. 2007;133:1858–1868. PubMed

Truninger K., Menigatti M., Luz J., Russell A., Haider R., Gebbers J.O., Bannwart F., Yurtsever H., Neuweiler J., Riehle H.M., Cattaruzza M.S., Heinimann K., Schar P., Jiricny J., Marra G. Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer. Gastroenterology. 2005;128:1160–1171. PubMed

Vasovcak P., Pavlikova K., Sedlacek Z., Skapa P., Kouda M., Hoch J., Krepelova A. Molecular genetic analysis of 103 sporadic colorectal tumours in czech patients. PLoS ONE. 2011;6:e24114. PubMed PMC

Wu Y., Nystrom-Lahti M., Osinga J., Looman M.W., Peltomaki P., Aaltonen L.A., de la Chapelle A., Hofstra R.M., Buys C.H. MSH2 and MLH1 mutations in sporadic replication error-positive colorectal carcinoma as assessed by two-dimensional DNA electrophoresis. Genes Chromosomes Cancer. 1997;18:269–278. PubMed

Han S.S., Cooper D.N., Upadhyaya M.N. Evaluation of denaturing high performance liquid chromatography (DHPLC) for the mutational analysis of the neurofibromatosis type 1 (NF1) gene. Hum. Genet. 2001;109:487–497. PubMed

Wu Y., Berends M.J., Mensink R.G., Kempinga C., Sijmons R.H., van Der Zee A.G., Hollema H., Kleibeuker J.H., Buys C.H., Hofstra R.M. Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Am. J. Hum. Genet. 1999;65:1291–1298. PubMed PMC

Old J.M. Detection of mutations by the amplification refractory mutation system (ARMS) In: Mathew Ch.G., editor. Protocols in Human Molecular Genetics. The Humana Press Inc.; 1992. pp. 77–84.

Miyoshi Y., Ando H., Nagase H., Nishisho I., Horii A., Miki Y., Mori T., Utsunomiya J., Baba S., Petersen G. Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc. Natl. Acad. Sci. U.S.A. 1992;89:4452–4456. PubMed PMC

Etzler J., Peyrl A., Zatkova A., Schildhaus H.U., Ficek A., Merkelbach-Bruse S., Kratz C.P., Attarbaschi A., Hainfellner J.A., Yao S., Messiaen L., Slavc I., Wimmer K. RNA-based mutation analysis identifies an unusual MSH6 splicing defect and circumvents PMS2 pseudogene interference. Hum. Mutat. 2008;29:299–305. PubMed

van der Klift H.M., Tops C.M., Bik E.C., Boogaard M.W., Borgstein A.M., Hansson K.B., Ausems M.G., Gomez G.E., Green A., Hes F.J., Izatt L., van Hest L.P., Alonso A.M., Vriends A.H., Wagner A., van Zelst-Stams W.A., Vasen H.F., Morreau H., Devilee P., Wijnen J.T. Quantification of sequence exchange events between PMS2 and PMS2CL provides a basis for improved mutation scanning of Lynch syndrome patients. Hum. Mutat. 2010;31:578–587. PubMed

A. Wernstedt, E. Valtorta, F. Armelao, R. Togni, S. Girlando, M. Baudis, K. Heinimann, L. Messiaen, N. Staehli, J. Zschocke, G. Marra, K. Wimmer, Improved MPLA analysis identifies a deleterious PMS2 allele generated by recombination with crossover between PMS2 and PMS2CL, Genes Chromosomes and Cancer (2012) (in press). PubMed PMC

Messiaen L., Wimmer K. Mutation analysis of the NF1 gene by cDNA-based sequencing of the coding region. In: Cunha K.S.G., Geller M., editors. Advances in Neurofibromatosis Research. Nova Science Publisher; 2011.

De Vos M., Hayward B.E., Picton S., Sheridan E., Bonthron D.T. Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome. Am. J. Hum. Genet. 2004;74:954–964. PubMed PMC

Wang Q., Montmain G., Ruano E., Upadhyaya M., Dudley S., Liskay R.M., Thibodeau S.N., Puisieux A. Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type. Hum. Genet. 2003;112:117–123. PubMed

Alotaibi H., Ricciardone M.D., Ozturk M. Homozygosity at variant MLH1 can lead to secondary mutation in NF1, neurofibromatosis type I and early onset leukemia. Mutat. Res. 2008;637:209–214. PubMed

Miyaki M., Nishio J., Konishi M., Kikuchi-Yanoshita R., Tanaka K., Muraoka M., Nagato M., Chong J.M., Koike M., Terada T., Kawahara Y., Fukutome A., Tomiyama J., Chuganji Y., Momoi M., Utsunomiya J. Drastic genetic instability of tumors and normal tissues in Turcot syndrome. Oncogene. 1997;15:2877–2881. PubMed

Kratz C.P., Niemeyer C.M., Juttner E., Kartal M., Weninger A., Schmitt-Graeff A., Kontny U., Lauten M., Utzolino S., Radecke J., Fonatsch C., Wimmer K. Childhood T-cell non-Hodgkin's lymphoma, colorectal carcinoma and brain tumor in association with cafe-au-lait spots caused by a novel homozygous PMS2 mutation. Leukemia. 2008;22:1078–1080. PubMed

Cortazar D., Kunz C., Saito Y., Steinacher R., Schar P. The enigmatic thymine DNA glycosylase. DNA Repair (Amst.) 2007;6:489–504. PubMed

Ramensky V., Bork P., Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 2002;30:3894–3900. PubMed PMC

Ng P.C., Henikoff S. Predicting deleterious amino acid substitutions. Genome Res. 2001;11:863–874. PubMed PMC

Grantham R. Amino acid difference formula to help explain protein evolution. Science. 1974;185:862–864. PubMed

Cortazar D., Kunz C., Selfridge J., Lettieri T., Saito Y., MacDougall E., Wirz A., Schuermann D., Jacobs A.L., Siegrist F., Steinacher R., Jiricny J., Bird A., Schar P. Embryonic lethal phenotype reveals a function of TDG in maintaining epigenetic stability. Nature. 2011;470:419–423. PubMed

Cortellino S., Xu J., Sannai M., Moore R., Caretti E., Cigliano A., Le C.M., Devarajan K., Wessels A., Soprano D., Abramowitz L.K., Bartolomei M.S., Rambow F., Bassi M.R., Bruno T., Fanciulli M., Renner C., Klein-Szanto A.J., Matsumoto Y., Kobi D., Davidson I., Alberti C., Larue L., Bellacosa A. Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell. 2011;146:67–79. PubMed PMC

Peng B., Hurt E.M., Hodge D.R., Thomas S.B., Farrar W.L. DNA hypermethylation and partial gene silencing of human thymine- DNA glycosylase in multiple myeloma cell lines. Epigenetics. 2006;1:138–145. PubMed

Sjoblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K., Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W., Velculescu V.E. The consensus coding sequences of human breast and colorectal cancers. Science. 2006;314:268–274. PubMed

Timmermann B., Kerick M., Roehr C., Fischer A., Isau M., Boerno S.T., Wunderlich A., Barmeyer C., Seemann P., Koenig J., Lappe M., Kuss A.W., Garshasbi M., Bertram L., Trappe K., Werber M., Herrmann B.G., Zatloukal K., Lehrach H., Schweiger M.R. Somatic mutation profiles of MSI and MSS colorectal cancer identified by whole exome next generation sequencing and bioinformatics analysis. PLoS ONE. 2010;5:e15661. PubMed PMC

Kunkel T.A., Erie D.A. DNA mismatch repair. Annu. Rev. Biochem. 2005;74:681–710. PubMed

Jiricny J. The multifaceted mismatch-repair system. Nat. Rev. Mol. Cell Biol. 2006;7:335–346. PubMed

Peltomaki P. Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum. Mol. Genet. 2001;10:735–740. PubMed

Vilkki S., Tsao J.L., Loukola A., Poyhonen M., Vierimaa O., Herva R., Aaltonen L.A., Shibata D. Extensive somatic microsatellite mutations in normal human tissue. Cancer Res. 2001;61:4541–4544. PubMed

Wang Q., Lasset C., Desseigne F., Frappaz D., Bergeron C., Navarro C., Ruano E., Puisieux A. Neurofibromatosis and early onset of cancers in hMLH1-deficient children. Cancer Res. 1999;59:294–297. PubMed

Agostini M., Tibiletti M.G., Lucci-Cordisco E., Chiaravalli A., Morreau H., Furlan D., Boccuto L., Pucciarelli S., Capella C., Boiocchi M., Viel A. Two PMS2 mutations in a Turcot syndrome family with small bowel cancers. Am. J. Gastroenterol. 2005;100:1886–1891. PubMed

Kunz C., Saito Y., Schar P. DNA Repair in mammalian cells: Mismatched repair: variations on a theme. Cell. Mol. Life Sci. 2009;66:1021–1038. PubMed PMC

Kavli B., Sundheim O., Akbari M., Otterlei M., Nilsen H., Skorpen F., Aas P.A., Hagen L., Krokan H.E., Slupphaug G. hUNG2 is the major repair enzyme for removal of uracil from U:A matches, U:G mismatches, and U in single-stranded DNA, with hSMUG1 as a broad specificity backup. J. Biol. Chem. 2002;277:39926–39936. PubMed

Pettersen H.S., Sundheim O., Gilljam K.M., Slupphaug G., Krokan H.E., Kavli B. Uracil-DNA glycosylases SMUG1 and UNG2 coordinate the initial steps of base excision repair by distinct mechanisms. Nucleic Acids Res. 2007;35:3879–3892. PubMed PMC

Brown T.C., Jiricny J. A specific mismatch repair event protects mammalian cells from loss of 5-methylcytosine. Cell. 1987;50:945–950. PubMed

Wiebauer K., Jiricny J. In vitro correction of G.T mispairs to G.C pairs in nuclear extracts from human cells. Nature. 1989;339:234–236. PubMed

Neddermann P., Gallinari P., Lettieri T., Schmid D., Truong O., Hsuan J.J., Wiebauer K., Jiricny J. Cloning and expression of human G/T mismatch-specific thymine-DNA glycosylase. J. Biol. Chem. 1996;271:12767–12774. PubMed

Bellacosa A. Role of MED1 (MBD4) gene in DNA repair and human cancer. J. Cell Physiol. 2001;187:137–144. PubMed

Hendrich B., Hardeland U., Ng H.H., Jiricny J., Bird A. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature. 1999;401:301–304. PubMed

Cattaneo E., Baudis M., Buffoli F., Bianco M.A., Zorzi F., Marra G. Springer Science + Business Media, LLC; 2010. Pathways and Crossroads to Colorectal Cancer, Pre-invasive Disease: Pathogenesis and Clinical Management.